HIV Glasgow: 4-Days-On-3-Days-Off HIV Treatment Controls Viral Load in Pilot Study
- Details
- Category: HIV Treatment
- Published on Monday, 14 November 2016 00:00
- Written by Keith Alcorn
An experimental "4 days on, 3 days off" antiretroviral regimen kept viral load fully suppressed in 96% of people for 48 weeks in a French study presented at the International Congress on Drug Therapy in HIV Infection (HIV Glasgow) last week. The study recruited people whose viral load had been fully suppressed on standard treatment for a median of 4 years, not people who had started therapy recently.
HIV Glasgow: Long-Acting HIV Fusion Inhibitor Albuvirtide Regimen Matches Standard Therapy
- Details
- Category: Experimental HIV Drugs
- Published on Monday, 07 November 2016 00:00
- Written by Keith Alcorn
A new fusion inhibitor, albuvirtide, under development in China, combined with a boosted protease inhibitor, proved just as effective as a triple regimen of lopinavir/ritonavir plus 2 NRTIs for treatment-experienced HIV patients, according to a report at the International Congress on Drug Therapy in HIV Infection last month in Glasgow.
HIV Glasgow: HIV Treatment Benefits Outweigh Clinical Impact of Lipodystrophy
- Details
- Category: GI, Metabolic & Lipodystrophy
- Published on Tuesday, 01 November 2016 00:00
- Written by Keith Alcorn
Over a 20-year period, people who suffered lipodystrophy (abnormal fat distribution) and especially lipoatrophy (fat loss) when they started antiretroviral therapy (ART) actually had better health outcomes than people who did not suffer from it, according to a report at the 2016 International Congress on Drug Therapy in HIV Infection (HIV Glasgow) last week.
HIV Glasgow: Darunavir/Ritonavir + Lamivudine Matches Triple-Drug HIV Therapy
- Details
- Category: Approved HIV Drugs
- Published on Monday, 07 November 2016 00:00
- Written by Keith Alcorn
Simplifying antiretroviral therapy to a 2-drug combination of lamivudine plus the protease inhibitor darunavir (Prezista) boosted by ritonavir is just as effective as a 3-drug regimen in people with suppressed viral load, Spanish investigators reported at the International Congress on Drug Therapy in HIV infection (HIV Glasgow) last month in Glasgow.
HIV Glasgow: Tests of Online PrEP Purchases Find No Fakes and Adequate Drug Levels
- Details
- Category: Pre-exposure Prophylaxis (PrEP)
- Published on Tuesday, 01 November 2016 00:00
- Written by Gus Cairns
A sexual health clinic in central London that offered to test drug levels in users of tenofovir/emtricitabine pre-exposure prophylaxis (PrEP) who had bought it online found adequate levels of both drugs in their blood, and no sample suggesting counterfeit drugs.
More Articles...
- HIV Glasgow: Generic Hepatitis C Drugs Purchased Online Produce High Cure Rates
- HIV Glasgow: French Study Reveals Growing Complexity of Medical Needs as People with HIV Age
- HIV Glasgow: Dolutegravir and Central Nervous System Side-Effects -- Abacavir, Older Age Increase the Risk
- HIV Glasgow: 2-Drug HIV Therapy Just as Effective as Standard 3-Drug Therapy
- HIV Glasgow: New $90-$90-$90 Target Needed for Global Viral Hepatitis, HIV, and TB Treatment
Web Design and Development by